Trials / Completed
CompletedNCT00454233
A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects
A Randomized, Double Blind, Placebo and Active Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Potential Efficacy of a 12-Week Treatment With YM543 in Subjects With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety of YM543 in type 2 Diabetes Mellitus patients and to investigate whether this study drug is effective in these patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM543 | Oral |
| DRUG | Metformin | Oral |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2007-03-30
- Last updated
- 2008-10-16
Locations
6 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT00454233. Inclusion in this directory is not an endorsement.